RSSDI'S Insulin Monograph

Section 1: Introduction

1. History of Insulin

2. Insulin Use in India's Challenges



Section 2: Basic Physiology and Pharmacology

3. Physiology of Insulin Secretion

4. Taxonomy of Insulin

5. Insulin Analogs



Section 3: Insulin Guidelines

6. Choosing an Insulin Regimen: Pragmatic Guidance

7. International Guideline Recommendations for Insulin Initiation

8. International Guidelines Recommendations for Insulin Intensification

9. South Asian Guidelines on Insulin Therapy

10. Insulin Monograph: Review of Important Clinical Trials with Insulin



Section 4: Clinical Insulinology

11. Premixed Insulin in Clinical Practice

12. High-mix Insulins

13. Basal Insulin

14. Insulin with Glucagon-like Peptide-1 Receptor Agonist

Coformulations

15. Insulin Coformulations (Insulin Degludec/Insulin Aspart)



Section 5: Advances in Insulin

16. Noninjectable Insulin

17. Ultrafast-acting Insulin

18. Smart Insulin

19. Insulin Delivery Devices: From Then to Now

20. Insulin Pump Therapy in Diabetes

21. Newer Insulins on the Horizon



Section 6: Special Populations

22. Insulin in Type 1 Diabetes Mellitus

23. Insulin in Renal Impairment

24. Insulin in the Elderly

25. Insulin Therapy in Diabetes and Pregnancy

26. Insulin in Infants



Section 7: Special Situations

27. Insulin Use in Complicated Diabetic Infections

28. Nondiabetic Use of Insulin

29. Insulin in Diabetic Ketoacidosis and Other Acute

Hyperglycemic Conditions

30. Hypoglycemia Prone Patients



Section 8: Technique and Monitoring

31. Insulin Technique: Simply Fitter

32. Insulin Storage in Extreme Climates

33. Self-monitoring of Blood Glucose with Insulin Therapy

34. Modern Means of Glycemic Monitoring

35. Green Use of Insulin

36. Local Issues of Insulin Injections



Section 9: Psychosocial Aspects of Diabetes

37. Breaking the Psychological Resistance to Insulin

38. Myths about Insulin Therapy



Section 10: Public Health and Insulin

39. Insulin in the National List of Essential Medicines

40. Insulin: The Regulatory and the Public Health Aspects

41. Cost Containment and Insulin

42. Social Marketing of Insulin



Section 11: Challenges in Insulin Treatment in the Young

43. Overcoming Challenges of Insulin Therapy in Young

44. Creating Support Structure for Children on Insulin Therapy

45. Resource Creation for Insulin Availability



Section 12: Managing Insulin Therapy in Hospital

46. Transitioning Insulin from Intravenous to Subcutaneous

47. Managing Patients on Steroids

48. Perioperative Management Using Insulin Therapy

49. Managing Patients on Enteral and Parenteral Nutrition

50. Patients During Labor